Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
Phase 2
Completed
- Conditions
- Depression
- Registration Number
- NCT00480207
- Lead Sponsor
- Prof. RH Belmaker
- Brief Summary
Our specific aim is to determine the impact of folic acid and omega-3 supplementation on the severity of depressive symptoms among depressed adults aged 65 and above.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Age 65+ (year of birth -1942 or below)
- Depression (as defined by the DSM-IV diagnostic criteria for depression: major or minor depression or dysthymia)
Exclusion Criteria
- Co-existing psychiatric disorder (except anxiety disorders)
- Moderate and severe cognitive impairment
- Current treatment with anticoagulants, antithrombotics and fibrinolytics
- Current severe angina with exertion
- Chronic renal insufficiency
- Liver cirrhosis
- Alcohol or drug abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method the severity of depressive symptoms baseline, 4th , 8th and 12th week
- Secondary Outcome Measures
Name Time Method nutritional status baseline and end of study possible side effects baseline, 4th, 8th, and 12th week cognitive status baseline, 4th, 8th, and 12th week
Trial Locations
- Locations (1)
Mental Health Center
🇮🇱Beer-Sheva, Israel
Mental Health Center🇮🇱Beer-Sheva, Israel